Format

Send to

Choose Destination
Best Pract Res Clin Rheumatol. 2016 Apr;30(2):279-295. doi: 10.1016/j.berh.2016.08.002. Epub 2016 Sep 16.

Behçet's disease: How to diagnose and treat vascular involvement.

Author information

1
University of Istanbul, Cerrahpasa Medical Faculty, Department of Medicine, Division of Rheumatology, Istanbul 81310, Turkey. Electronic address: eseyahi@yahoo.com.

Abstract

Behçet's disease is a multisystem disorder with unknown etiology and a unique geographic distribution. The disease is characterized by recurrent skin-mucosa lesions and sight-threatening panuveitis. Vascular involvement, which is more common and more severe among males, has also equally characteristic features such as affecting mostly veins, having a significant tendency for thrombosis, and running a relapsing course. Lower extremity vein thrombosis (LEVT) is the most frequent manifestation, followed by vena cava inferior thrombosis. Pulmonary artery involvement (PAI), the most common form of arterial involvement, manifests as aneurysms and "in situ" thrombosis. PAI and Budd-Chiari syndrome are the leading causes of increased mortality. In vascular cluster, typically, several types of venous or arterial vascular involvement may accumulate in the same individual. LEVT or cerebral venous sinus thrombosis is often present in these subgroups as the first event. Immunosuppressive treatment is essential in preventing the attacks and increasing survival.

KEYWORDS:

Anticoagulation; Azathioprine; Behçet's disease; Lower extremity vein thrombosis; Pulmonary artery aneurysms; Thrombosis; Vasculitis; Vena cava thrombosis

PMID:
27886800
DOI:
10.1016/j.berh.2016.08.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center